Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma
2020 · Journal of Experimental & Clinical Cancer Research · 30 citations
https://doi.org/10.1186/s13046-020-1527-y
M
Morgan E. Roberts
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
911
Citations
14
h-index
16
i10-index
Morgan E. Roberts is an academic researcher from University of British Columbia. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction. The author has an h-index of 14, co-authored 46 publications.
ORCID: 0000-0002-5850-7985Papers by this author
worksDevelopment of a bispecific immune engager using a recombinant malaria protein
2021 · Cell Death and Disease · 10 citations
https://doi.org/10.1038/s41419-021-03611-0
A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer
2023 · iScience · 7 citations
https://doi.org/10.1016/j.isci.2023.106525
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors
2024 · EMBO Molecular Medicine · 7 citations
https://doi.org/10.1038/s44321-024-00153-8
Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy
2025 · Nature Communications · 7 citations
https://doi.org/10.1038/s41467-024-55665-1
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
2019 · Nature Communications · 4 citations
https://doi.org/10.1038/s41467-019-10666-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat